# Cancer Drugs

| Drug            | Target Gene        | Objective                                                                 | Reference                                  |
|-----------------|--------------------|---------------------------------------------------------------------------|--------------------------------------------|
| 5-FU            | TYMS - DNA         | DNA Replication Inhibitor <br> DNA/RNA Damage                             | Longley et al. (2003)                      |
| ABT-888         | PARP               | DNA Repair Inhibitor                                                      | -                                          |
| Sunitinib       | RTK Groups         | Cell Growth Blocker                                                       | Papaetis et al. (2009)                     |
| Sorafenib       | RTK Groups         | Cell Growth Blocker                                                       | Grandinetti et al. (2007)                  |
| Erlotinib       | EGFR               | Proliferation Inhibitor <br> Apoptosis Activator                          | -                                          |
| Oxaliplatin     | DNA                | DNA Damage                                                                | -                                          |
| Vinblastine     | Tubulin Groups     | Cell Division Inhibitor                                                   | Ngan et al. (2000)                         |
| AZD1775         | Wee1               | Apoptosis Activator <br> (Mitosis Activator with Damaged DNA)             | -                                          |
| L-778123        | FNTA               | Cell Proliferation <br> (RAS) Inhibitor                                   | Si et al. (2005)                           |
| BEZ-235         | PI3K - mTOR        | Cell Growth Blocker <br> Metabolism Blocker                               | Mishra et al. (2021)                       |
| Dinaciclib      | CDK                | Cell Cycle Blocker                                                        | Zhang et al. (2021)                        |
| Geldanamycin    | HSP90              | Onco-protein Stabilization Inhibitor                                      | Birbo et al. (2021)                        |
| MK-2206         | AKT                | Down-regulation of Cell Growth and Proliferation                          | Nitulescu et al. (2015)                    |
| MK-4827         | PARP               | DNA Repair Inhibitor                                                      | Wang et al. (2012)                         |
| MK-5108         | AURKA              | Mitosis Inhibitor                                                         | Du et al. (2021)                           |
| MK-8669         | mTOR               | Cell Growth Blocker <br> Metabolism Blocker                               | -                                          |
| MK-8776         | CHEK1              | DNA Damage Accumulation <br> Cell Cycle Breaker                           | Qiu et al. (2018)                          |
| MRK-003         | Î³-Secretase        | Proliferation Inhibitor <br> Apoptosis Activator <br> (Notch Suppressor)  | Mizuma et al. (2012)                       |
| PD-0325901      | MEK1 - MEK2        | Proliferation Inhibitor <br> Apoptosis Activator                          | Haura et al. (2010)                        |
| Bortezomib      | 26S Proteasome     | Cell Cycle Breaker <br> Apoptosis Activator                               | Shahshahan et al. (2011)                   |
| Dasatinib       | Abl/Src Kinase     | Cell Growth Blocker                                                       | Konig et al. (2008)                        |
| Lapatinib       | EGFR-HER2          | Cell Growth Blocker                                                       | Konecny et al. (2008)                      |
| Temozolomide    | DNA                | DNA Damage                                                                | Stupp et al. (2001)                        |
| Zolinza         | HDAC Groups        | Cell Growth Inhibitor <br> Apoptosis Activator                            | Blumenschein et al. (2008)                 |
| Carboplatin     | DNA                | DNA Damage                                                                | Wagstaff et al. (1989)                     |
| Cyclophosphamide| DNA                | DNA Damage                                                                | Emadi et al. (2009)                        |
| Dexamethasone   | NR3C1              | Immunomodulator                                                           | Cook et al. (2016)                         |
| Doxorubicin     | TOP2A - TOP2B      | Double Strand Break Accumulation                                          | Nitiss et al. (2009)                       |
| Etoposide       | TOP2A              | Double Strand Break Accumulation                                          | Sung et al. (2006)                         |
| Gemcitabine     | RRM1               | DNA Synthesis Inhibitor                                                   | Tanaka et al. (2010)                       |
| Metformin       | AMPK               | Proliferation Inhibitor <br> Apoptosis Activator                          | Goel et al. (2022)                         |
| Vinorelbine     | Tubulin Groups     | Cell Division Inhibitor                                                   | Ngan et al. (2000)                         |
| Methotrexate    | DHFR               | Nucleotide Synthesis Inhibitor                                            | Sramek et al. (2016)                       |
| Paclitaxel      | Tubulin Groups     | Cell Division Inhibitor                                                   | Perez et al. (2009)                        |

